Newsfeeds - Spark Newswire

3 minute read

NLS Pharmaceutics Announces Preclinical Results From Study Of NLS-4 For Circadian Rhythm Dysregulation And Chronic Fatigue Syndrome In Long-Covid Model

Today, 10:28 PM

NLS Pharmaceutics Ltd. (NASDAQ:NLSP, NLSPW)))) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients

NLSP

1 minute read

From BZ’s Small Cap Healthcare Conference: NLS Pharmaceuticals Co-Founder & CEO, Alexander Zwyer Begins Speaking

By Zoltan Suranyi

Today, 10:28 PM

Click To Tune In Here... https://www.youtube.com/watch?v=KS30Mcu5ei8

NLSP

3 minute read

News

NLS Pharma 6-K Shows Co. Entered Standby Equity Distribution Deal With YA II PN Ltd: Co. Will Be Able To Sell Up To $20M In Common Shares At Co.’s Option During 3-Year Period

By Benzinga Newsdesk

Today, 10:28 PM

On September 27, 2021, NLS Pharmaceutics Ltd., or the Company, entered into a Standby Equity Distribution Agreement, or the SEDA, with YA II PN, Ltd. or YA. Pursuant to the SEDA, the Company will be able to sell up to

NLSP

5 minute read

58 Biggest Movers From Friday

By Lisa Levin

Today, 10:28 PM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.

AMRS

3 minute read

38 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 10:28 PM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 175% to $17.33. Regencell Bioscience reported partial exercise of underwriter’s over-allotment option.

ARAY

3 minute read

22 Stocks Moving in Friday’s Pre-Market Session

By Lisa Levin

Today, 10:28 PM

Gainers GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society of Medicine General Assembly.

AZRX

1 minute read

NLS Pharma Stock Gains After Issuance Of Mazindol Patent

By Vandana Singh

Today, 10:28 PM

NLS Pharmaceutics Ltd (NASDAQ:NLSP) has received a Notice of Allowance from the U.S. Patent and Trademark Office for patent application No.…

NLSP

1 minute read

NLS Pharma Stock Gains As Its Narcolepsy Candidate To Enter Mid-Stage Study Next Month

By Vandana Singh

Today, 10:28 PM

The FDA has accepted NLS Pharmaceutics Ltd’s (NASDAQ:NLSP) Investigational New Drug application for Quilience (mazindol extended-release (mazindol ER), the Company’s lead…

NLSP

1 minute read

NLS Pharmaceutics Shares Move Higher; Co Announces FDA Acceptance Of IND Application To Initiate Clinical Trials With Quilience(R) (mazindol ER) To Treat Narcolepsy

By Benzinga Newsdesk

Today, 10:28 PM

NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients

NLSP